Hadassah

International Conference on Challenges in Liver Disease Honors World-Renowned Hadassah Liver Specialist

Thursday, Jan 31 2013

About 200 health professionals--including 20 of the world's leading liver specialists from France, Germany, Israel, Italy, the United Kingdom, and the United States--attended an international conference on liver disease at the Hadassah Medical Center in January, where they honored Hadassah's Prof. Daniel Shouval upon his 70th birthday.

In 1983, Prof. Shouval established the first liver unit in Israel at Hadassah, which he directed for almost 30 years until his recent retirement. During his very long career at the Medical Center, Prof. Shouval was responsible for many breakthroughs, created generations of fine liver experts, and published many pivotal research papers. The new head of Hadassah's Liver Unit, Dr. Rifaat Safadi of Nazareth, had worked alongside Dr. Shouval for 20 years.

"Diagnosis and treatment of liver diseases has made very significant progress in recent years," notes Prof. Shouval. "Israel is among the most advanced countries in the world in preventing and treating viral liver diseases." Prof. Shouval's research and involvement were most influential in a decision by the Israeli government in 1999 to introduce a full-scale national vaccination program for babies against Hepatitis B. This led to a 95 percent decline in Hepatitis B for adults in Israel. Israel was among the first 10 countries worldwide to institute this program.

A former Dean of the Hadassah-Hebrew University Faculty of Medicine, Prof. Shouval currently serves as a professor of medicine at Hebrew University and a visiting professor at the Yeshiva University's Albert Einstein College of Medicine in New York. During his career, he has held similar positions at the Harvard Medical School and Massachusetts General Hospital in Boston and the University of Paris in France, and worked in several liver research centers in the United Kingdom, France, and the United States.

Prof. Shouval is the recipient of several national and international awards and the author of over 200 articles and chapters in medical text books. He served as President of the European Association for the Study of the Liver and Chairman of the Educational Committee of the European Association for the Study of the Liver. In this capacity, he became involved in education about Hepatology and the prevention of liver disease worldwide.

A permanent adviser to the European Viral Hepatitis Prevention Board and the World Health Organization, Prof. Shouval was Associate Editor of The Journal of Liver Transplantation and a member of the editorial boards of several leading hepatology journals.

The Conference, entitled "New Challenges in the Diagnosis and Treatment of Liver Diseases," was sponsored by Hadassah, the Hebrew University, and the European and Israeli societies for study of the liver.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Jan 13 2017

Saving Children in the Nick of Time at Hadassah

When a four-year-old, blue and critically ill, was rushed into the pediatric emergency room at Hadassah Hospital Mount Scopus, Dr. David Rekhtman, head of the ER, and his team deciphered that the child had somehow consumed methadone.

READ MORE ›
alt_text

Friday, Jan 13 2017

Peace in Sight: An Israeli, Palestinian, and Hadassah Australia Collaboration

St. John of Jerusalem Eye Hospital, in collaboration with Hadassah Medical Center, has received a €500,000 grant from the European Union to establish a genetic research unit to serve the Palestinian communities.

READ MORE ›
alt_text

Friday, Jan 13 2017

A Second Chance at Life, Thanks to Hadassah’s Heart Institute

A resident of a rural settlement called Dishon, established by Libyan Jewish immigrants in 1953, Eyal Amar, age 47, was rather young to suffer a devastating heart attack. Nevertheless, he did, but thanks to the courage and skill of the specialists at the Hadassah Medical Organization’s Heart Institute and their complex protocol to redesign his heavily damaged heart, Eyal is able to walk and breathe again.

READ MORE ›
alt_text

Tuesday, Jan 10 2017

From Locked Jaw to Osteoarthritis: Hadassah Discovery Leads to New Treatment

What began as a solution to locked jaw--temporomandibular joint (TMJ) disorder--has led to the creation of a novel non-opioid pharmaceutical candidate for the treatment of osteoarthritis pain, thanks to a Hadassah Medical Organization discovery and collaboration with colleagues at the Hebrew University and the Technion.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More